carbamates has been researched along with Rectal Neoplasms in 2 studies
Rectal Neoplasms: Tumors or cancer of the RECTUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Encorafenib is a BRAF inhibitor increasingly used as a second-line treatment for metastatic melanoma and colorectal cancer." | 1.72 | Eruptive naevi associated with encorafenib for metastatic colorectal cancer: two cases. ( Alfallouji, Y; Borysiewicz, C; Bunker, CB; Calonje, E; Hodgkinson, T; Perrett, CM; Sidwell, RU; Spencer, A; Wasan, H; Watchorn, R, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alfallouji, Y | 1 |
| Spencer, A | 1 |
| Calonje, E | 1 |
| Perrett, CM | 1 |
| Watchorn, R | 1 |
| Borysiewicz, C | 1 |
| Hodgkinson, T | 1 |
| Wasan, H | 1 |
| Bunker, CB | 1 |
| Sidwell, RU | 1 |
| Ajani, JA | 1 |
| Hortobagyi, GN | 1 |
| Frye, D | 1 |
| Levin, B | 1 |
| Boman, BM | 1 |
| Faintuch, JS | 1 |
1 trial available for carbamates and Rectal Neoplasms
| Article | Year |
|---|---|
A randomized study of two schedules of copovithane in patients with advanced colorectal carcinoma.
Topics: Antineoplastic Agents; Carbamates; Carcinoma; Clinical Trials as Topic; Colonic Neoplasms; Humans; P | 1987 |
1 other study available for carbamates and Rectal Neoplasms
| Article | Year |
|---|---|
Eruptive naevi associated with encorafenib for metastatic colorectal cancer: two cases.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carbamates; Colonic Neoplasms; Exanthema; Humans; Mu | 2022 |